Company intelligence / Profile preview

BROC SHOT

New York, New York, United Statesbrocshot.com ↗

Ownership: Private
Employees: ~10
Development stage: Other

Overview

BROC SHOT is a wellness and nutraceutical company focused on the health benefits of sulforaphane, a potent compound derived from broccoli sprouts. The company produces concentrated 2-ounce shots designed to activate the Nrf2 pathway, which regulates the body's natural antioxidant response and detoxification processes. Their products are marketed for improving skin clarity, enhancing gut health, boosting cognitive function, and reducing inflammation. By utilizing a specialized formulation that ensures the stability and bioavailability of sulforaphane, BROC SHOT aims to provide a convenient, science-backed solution for cellular health and longevity.

Therapeutic areas: NeurologyMetabolic DisordersDermatologyGastroenterologyImmunology
Modalities: Small moleculeNutraceutical
Industry: Food & Nutrition

Beyond the preview

Go deeper on BROC SHOT.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BROC SHOT.

Explore the full profile